SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
ImClone Systems Incorporated
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
45245W109
--------------------------------------------------------------------------------
(CUSIP Number)
December 5, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
--------------------------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes.)
<PAGE>
13G
--------------------------------------------- --------------------------------
CUSIP No. 45245W109 Page 2 of 5 Pages
--------------------------------------------- --------------------------------
---------- ---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Merck KGaA
---------- ---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
---------- ---------------------------------------------------------------------
3. SEC USE ONLY
---------- ---------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Republic of Germany
--------------------------------------- --------- ------------------------------
SOLE VOTING POWER
5.
2,099,200
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH
--------------------------------------- --------- ------------------------------
SHARED VOTING POWER
6.
0
--------- ------------------------------
SOLE DISPOSITIVE POWER
7.
2,099,200
--------- ------------------------------
SHARED DISPOSITIVE POWER
8.
0
---------- ---------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,099,200
---------- ---------------------------------------------------------------------
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES* |_|
---------- ---------------------------------------------------------------------
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.5%
---------- ---------------------------------------------------------------------
12.
TYPE OF REPORTING PERSON*
CO
---------- ---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1(a). Name of Issuer:
ImClone Systems Incorporated
Item 1(b). Address of Issuer's Principal Executive Offices:
180 Varick Street, New York, NY 10014
Item 2(a). Name of Person Filing:
Merck KGaA
Item 2(b). Address of Principal Business Office or, if None, Residence:
Frankfurter Strasse 250, D-64293 Darmstadt, Federal Republic of Germany
Item 2(c). Citizenship:
Federal Republic of Germany
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.001 per share
Item 2(e). CUSIP Number:
45245W109
Item 3. If This Statement is Filed Pursuant to Rule 13d-1 (b), or 13d-2 (b) or
(c), Check Whether the Person Filing is a:
(a) |_| Broker or dealer registered under Section 15 of the
Exchange Act.
(b) |_| Bank as defined in Section 3 (a) (6) of the Exchange
Act.
(c) |_| Insurance company as defined in Section 3 (a) (19) of
the Exchange Act.
(d) |_| Investment company registered under Section 8 of the
Investment Company Act.
(e) |_| An investment adviser in accordance with
Rule 13d-1 (b) (1) (ii) (E);
(f) |_| An employee benefit plan or endowment fund in
accordance with Rule 13d-1 (b) (1) (ii) (F);
(g) |_| A parent holding company or control person in
accordance with Rule 13d-1 (b) (1) (ii) (G)
(h) |_| A savings association as defined in Section 3 (b) of
the Federal Deposit Insurance Act;
(i) |_| A church plan that is excluded from the definition of
an investment company under Section 3 (c) (14) of the
Investment Company Act;
(j) |_| Group, in accordance with Rule 13d-1 (b) (1) (ii) (J).
<PAGE>
Item 4. Ownership.
(a) Amount beneficially held:
2,099,200 shares
(b) Percent of class:
6.5%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
2,099,200
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
2,099,200
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class.
NOT APPLICABLE.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
NOT APPLICABLE.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
NOT APPLICABLE.
Item 8. Identification and Classification of Members of the Group.
NOT APPLICABLE.
Item 9. Notice of Dissolution of Group.
NOT APPLICABLE.
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: January 11, 2001
MERCK KGaA
By: /s/ Michael Volz
----------------
Name: Michael Volz
Title: Legal Counsel
